Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
BMJ Oncology|January 31, 2025
Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with 'persister' cell profiles fail to benefit from adjuvant chemotherapySanghee Cho, Elizabeth McDonough, John Graf, et al.
BMJ Oncology|January 31, 2025
PACT-UK (PAncreatic Cancer reporting Template-UK): a cross-specialty multi-institutional consensus panel development of a standardised radiological reporting proforma for pancreatic cancerJohn Moir, Ganesh Radhakrishna, Juan W Valle, et al.
BMJ Oncology|January 31, 2025
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE studyMark A Baxter, Michael Rowe, Kieran Zucker, et al.
BMJ Oncology|January 31, 2025
Challenges faced by women oncologists in Africa: a mixed methods studyMiriam Mutebi, Naa Adorkor Aryeetey, Haimanot Kasahun Alemu, et al.
BMJ Oncology|January 31, 2025
Surgical management of skull base chordomas and chondrosarcomas: insights from a national cohort studyLaurence J Glancz, Cathal John Hannan, Alexandros Vyziotis, et al.
BMJ Oncology|January 31, 2025
Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysisAmin Ali, Thiraviyam Elumalai, BhanuPrasad Venkatesulu, et al.
BMJ Oncology|January 31, 2025
How do tumours outside the gastrointestinal tract respond to dietary fibre supplementation?Fatima Asim, Lowenna Clarke, Elizabeth Donnelly, et al.
BMJ Oncology|January 31, 2025
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date reviewAlberto Giovanni Leone, Stefania Bonadonna, Chiara Cassani, et al.
BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.
BMJ Oncology|March 6, 2025
Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysisHui-Chuan Sun, Xiao-Dong Zhu, Zi-Yi Wang, et al.
Pageof 17